562 related articles for article (PubMed ID: 35699161)
1. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment.
Zhang Y; Chen X; Jia L; Zhang Y
Acta Neurol Scand; 2022 Sep; 146(3):225-236. PubMed ID: 35699161
[TBL] [Abstract][Full Text] [Related]
2. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
4. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
5. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
6. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
[TBL] [Abstract][Full Text] [Related]
7. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
8. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
Pouga L
J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in the nervous system: physiopathology and neurological manifestations.
Mendonça Filho VCM; de Oliveira AG; Maia IFVC; de Falcone ACM; Betini BG; Rezende LB; Magri Alves FH
Arq Neuropsiquiatr; 2023 Aug; 81(8):756-763. PubMed ID: 37402400
[TBL] [Abstract][Full Text] [Related]
10. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
[TBL] [Abstract][Full Text] [Related]
11. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between SARS-CoV-2 Infection and Neurological Disorders: A Review.
Azhar A; Wali MA; Rashid Q; Khan WH; Al-Hosaini K; Owais M; Kamal MA
CNS Neurol Disord Drug Targets; 2023; 22(5):643-658. PubMed ID: 35440321
[TBL] [Abstract][Full Text] [Related]
13. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches.
Mahboubi Mehrabani M; Karvandi MS; Maafi P; Doroudian M
Rev Med Virol; 2022 Nov; 32(6):e2334. PubMed ID: 35138001
[TBL] [Abstract][Full Text] [Related]
14. Nervous system manifestations related to COVID-19 and their possible mechanisms.
Xie Z; Hui H; Zhao Z; Yu W; Wu R; Zhu Y; Song Y; Cao B; Shi W; Zhao D; Zhao Y; Lv J; Yao Q; Duan Y; Li J; Zhang H; Zhou L; Wang X; Tian Y; Zhao G
Brain Res Bull; 2022 Sep; 187():63-74. PubMed ID: 35772604
[TBL] [Abstract][Full Text] [Related]
15. Emerging neurotropic features of SARS-CoV-2.
Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences.
Jafari Khaljiri H; Jamalkhah M; Amini Harandi A; Pakdaman H; Moradi M; Mowla A
Neurotox Res; 2021 Oct; 39(5):1613-1629. PubMed ID: 34169404
[TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system.
Alam SB; Willows S; Kulka M; Sandhu JK
Eur J Neurol; 2020 Nov; 27(11):2348-2360. PubMed ID: 32668062
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and its effects on neurological functions.
Yew MMT; Lip JQ; Ling APK
Trop Biomed; 2021 Sep; 38(3):435-445. PubMed ID: 34608117
[TBL] [Abstract][Full Text] [Related]
20. Peripheral nervous system involvement in SARS-CoV-2 infection: a review of the current pediatric literature.
Perilli L; Fetta M; Capponi M; Guido CA; Grosso S; Iannetti P; Spalice A
Front Neurol; 2023; 14():1134507. PubMed ID: 37305745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]